erythroleukemia

Also found in: Medical, Wikipedia.

erythroleukemia

a malignancy of the blood characterized by abnormally productive bone marrow and the development of oddly-shaped blood cells.
See also: Cancer
-Ologies & -Isms. Copyright 2008 The Gale Group, Inc. All rights reserved.
Translations

e·ryth·ro·leu·ke·mi·a

n. eritroleucemia, enfermedad sanguínea maligna caracterizada por el crecimiento anormal de glóbulos rojos y blancos.
English-Spanish Medical Dictionary © Farlex 2012
Mentioned in
References in periodicals archive
Lim, "Co-culture of stromal and erythroleukemia cells in a perfused hollow fiber bioreactor system as an in vitro bone marrow model for myeloid leukemia," Biotechnology and Bioengineering, vol.
Thus, in vitro assays showed that activated NK cells from aMCI and mAD patients lyse K562 cells, an erythroleukemia cell line [94].
The human erythroleukemia cell line K562 was purchased from ATCC and used as a control target for NK cell functional assays.
Thus, for example, diosgenin has antiproliferativeactivity, namely, inprostatecancer(PC-3 and DU-145 cells) [23], colon carcinoma (HCT-116 and HT-29 cells) [24], erythroleukemia (HEL cells) [27], squamous carcinoma (A431, Hep2, and RPMI2650 cells) [28], hepatocellular carcinoma (HepG2 and HCC cells) [6,25,29], gastric cancer (BGC-823 cells) [30], lung cancer (A549 cells) [31], breast cancer (MCF-7) [6,32-34], and human chronic myeloid leukemia (CML) (K562 cells) [1].
Moreover, diosgenin induces megakaryocytic differentiation of human erythroleukemia cells through ERK and sonic hedgehog pathway activation (Fernandez-Zapico et al.
Reductions in gamma-globin mRNA levels restricted to the cytoplasm of 5-fluorouridine treated K-562 human erythroleukemia cells.
Leukemia, refers to white blood cell malignancies with the exception for erythroleukemia (AML-M6) which arises from precursors of RBCs.
The first, also called erythroleukemia, involves myeloblasts and rubriblasts (BENNETT et al., 1976).
nucifera (typical A variety, commonly known as "olho-de-cravo", and the common variety) were tested on human erythroleukemia cell line K562 and Lucena 1, a multidrug-resistant (MDR) and vincristine-resistant derivative of K562.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.